cyclophosphamide
FDA Approved
Description
Cyclophosphamide is an alkylating agent and immunosuppressive drug used to treat severe autoimmune diseases and certain cancers. In vasculitis, it is used for induction therapy in severe or refractory cases. It works by interfering with DNA replication and suppressing immune system activity.
Indications & Therapeutic Use
systemic vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, lupus nephritis, lymphomas, leukemias
Linked Diseases:
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
cyclophosphamide
| Generic Name | cyclophosphamide |
| Brands | 1 brand available |
| Active Ingredient | cyclophosphamide |
| Drug Class | systemic vasculitis |
| Manufacturer | Baxter Healthcare |
| Dosage Forms | oral tablet 25mg, 50mg; IV infusion 500mg, 1g, 2g vials |
| Medical Code | L01AA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00001758 |
| Countries | 7 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations8 Validated Nodes